SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors eagerly await the imminent release of topline Phase 3 data for its wet AMD treatment, AXPAXLI. The community is buzzing with speculation about a potential acquisition by Sanofi at a significantly higher bid than previously offered, alongside strong bullish sentiment driven by management's strategic data presentation at a major retina conference and recent institutional accumulation, despite the inherent binary risk of the biotech catalyst.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is currently trending with volatile overnight futures driving a divided community sentiment, as traders debate whether current movements signal a sustained downturn or a buying opportunity, amidst broader discussions on geopolitical tensions and evolving economic data impacting the market.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending as its highly engaged community champions a "SENDU TRENDU" movement, actively building a permissionless brand with numerous real-world products and initiatives. Despite broader market conditions, the community's strong conviction and relentless efforts highlight KENDU as a resilient, long-term play.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Infleqtion Inc. - Ordinary Shares - Class A

Churchill Capital Corp X 

With an exceptionally low redemption rate and recent major contracts with NASA and the DOE, Churchill Capital Corp X (CCCX) is trending. The community is highly bullish, eagerly anticipating its upcoming NYSE debut as Infleqtion (INFQ) and positioning it as an undervalued leader in quantum technology.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as Hapag-Lloyd officially agreed to acquire the company for $35 a share, igniting widespread speculation on a potential short squeeze while the community debates if the offer truly values the shipping giant and whether the deal will overcome Israeli governmental and worker opposition given its strategic national role.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is trending following an abrupt CEO change, with John Chidsey taking the helm amidst retail optimism for a turnaround after widespread criticism of the former leadership. This leadership transition and new ship orders are being closely watched, especially as community outrage mounts over recent analyst downgrades perceived as punitive rather than fundamental.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is actively discussed amidst persistent buyout speculation from major tech players coveting its unique n53 spectrum, essential for direct-to-device connectivity and private 5G networks. The community is keenly awaiting pivotal FCC decisions, which are anticipated to unlock significant value and accelerate the company's strategic growth.

PepeCoin is a meme token based on the character Pepe the Frog. Initially launched in March 2016 on its own blockchain, it later migrated to Ethereum. PepeCoin is recognized as the original Pepe currency due to its long history.   The project aims to provide a variety of use cases, transforming PepeCoin into a memecoin with utility.  The community is primarily focused on creating a fun atmosphere, actively engaging in various events to enhance the token's growth and visibility. Additionally, PepeCoin is developing a game that will serve as an interactive social Web 3.0 video game platform, further expanding its ecosystem and fostering interaction among users.

PepeCoin

PEPECOIN is drawing significant community attention as investors highlight its status as the original, mineable Pepe token with developing utility like Kekspace and integration with BasedAI. The narrative emphasizes its deflationary model and robust ecosystem as a contrast to other meme coins, sparking discussions of an impending 'flippening' as its true value is recognized.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is a focus of strong debate, with tech facing pressure from AI disruption fears and recent selling, while bulls anticipate a rebound amid expectations of rate cuts; all eyes are on market open following the holiday, given mixed futures activity.

Tidal Trust II - YieldMax COIN Option Income Strategy ETF

YieldMax COIN Option Income Strategy ETF

YieldMax COIN Option Income Strategy ETF ($CONY) is a central topic among investors grappling with its covered call strategy after Coinbase's performance, with widespread community discussion fueled by recent reverse splits across YieldMax products and the fund's shift to weekly distributions. This has prompted significant debate on dividend sustainability versus ongoing NAV erosion, as many assess long-term strategies for compounding returns despite volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Equities Analysts Set Expectations for CRDL FY2025 Earnings

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Research analysts at Brookline Cap M issued their FY2025 EPS estimates for shares of Cardiol Therapeutics in a note issued to investors on...

Cardiol Therapeutics (NASDAQ:CRDL) Stock Rating Upgraded by Brookline Cap M

Brookline Cap M upgraded shares of Cardiol Therapeutics to a "strong-buy" rating in a research report on Tuesday...

Analysts Offer Predictions for CRDL FY2025 Earnings

Cardiol Therapeutics Inc. (NASDAQ:CRDL - Free Report) - Stock analysts at Brookline Capital Management issued their FY2025 earnings per share estimates for Cardiol Therapeutics in a research report...

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - Time to Sell?

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - Here's What Happened...

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% - What's Next?

Cardiol Therapeutics (TSE:CRDL) Trading Down 7.1% - What's Next...

Cardiol Therapeutics (NASDAQ:CRDL) Raised to Strong-Buy at Brookline Capital Management

Brookline Capital Management upgraded shares of Cardiol Therapeutics to a "strong-buy" rating in a research note on Tuesday...

Cardiol Therapeutics (TSE:CRDL) Stock Price Up 1.5% - Still a Buy?

Cardiol Therapeutics (TSE:CRDL) Trading 1.5% Higher - What's Next...

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 0.7% - Here's Why

Cardiol Therapeutics (TSE:CRDL) Trading Down 0.7% - Here's What Happened...

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Average Recommendation of "Buy" by Brokerages

Shares of Cardiol Therapeutics Inc. (NASDAQ:CRDL - Get Free Report) have received a consensus rating of "Buy" from the five research firms that are covering the stock, MarketBeat reports. One...

Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $9.00 price objective on shares of Cardiol Therapeutics in a report on Monday...

Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. The firm is conducting clinical studies to evaluate the efficacy and safety of CardiolRx in diseases affecting the heart: a Phase II multi-national, randomized, double-blind, placebo-controlled trial (the ARCHER trial) in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis. It is also involved in developing a novel subcutaneously administered drug formulation of cannabidiol intended for use in heart failure. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada.

Cardiol Therapeutics Inc - Ordinary Shares - Class A

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

CRDL
Cardiol Therapeutics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRDL News

CRDLCardiol Therapeutics Inc - Ordinary Shares - Class A